Q4 2023 · 13F-HR
Lion Point Capital, LPholdings as filed
Filed 2024-02-14 · accession 0001013594-24-000191
$199.9M
Reported value
30
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 816850101 | SMTC | SEMTECH CORP | $56.5M | 28.3% | 2,577,855 | Common | SOLE |
| 816850101 | SMTC | SEMTECH CORP | $54.8M | 27.4% | 2,500,000 | CALL | SOLE |
| 464287655 | IWM | ISHARES TR | $33.1M | 16.6% | 165,000 | PUT | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $23.2M | 11.6% | 2,134,337 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $7.1M | 3.57% | 1,151,667 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $2.8M | 1.38% | 1,650,207 | Common | SOLE |
| 41358P205 | HARPUSD | HARPOON THERAPEUTICS INC | $2.6M | 1.30% | 228,900 | Common | SOLE |
| 12122L101 | 0LS | BURGERFI INTERNATIONAL INC | $2.4M | 1.18% | 2,745,938 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $2.3M | 1.15% | 130,691 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $2.2M | 1.09% | 70,335 | Common | SOLE |
| 07134L107 | BATL | BATTALION OIL CORPORATION | $2.1M | 1.07% | 222,182 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $1.9M | 0.97% | 82,425 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $1.2M | 0.62% | 110,000 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $1.1M | 0.57% | 80,000 | Common | SOLE |
| G3167L109 | — | ENPHYS ACQUISITION CORP | $833,594 | 0.42% | 78,125 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $745,545 | 0.37% | 34,500 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $733,133 | 0.37% | 531,256 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $701,220 | 0.35% | 78,000 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $670,740 | 0.34% | 1,000,000 | Common | SOLE |
| 44486Q103 | HUMA | HUMACYTE INC | $667,400 | 0.33% | 235,000 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $477,065 | 0.24% | 340,761 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $398,520 | 0.20% | 13,500 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $358,275 | 0.18% | 42,500 | Common | SOLE |
| 55028X109 | 4NX1 | LUMOS PHARMA INC | $288,725 | 0.14% | 90,794 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $206,080 | 0.10% | 14,000 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $166,494 | 0.08% | 82,423 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $121,693 | 0.06% | 115,898 | Common | SOLE |
| 12122L119 | — | BURGERFI INTERNATIONAL INC | $93,755 | 0.05% | 2,083,438 | Common | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $37,604 | 0.02% | 100 | Common | SOLE |
| 02079K107 | GOOG | ALPHABET INC | $14,093 | 0.01% | 100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.